悪性貧血診断および治療の世界市場レポート 2025年

悪性貧血診断および治療の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.8％で19億7,000万米ドルに成長します。予測期間中の成長は、遠隔医療サービスの拡大、早期診断に対する需要の増加、個別化医療への注目の高まり、政府の検診イニシアティブ、非侵襲的治療に対する患者の嗜好の高まりなどに起因しています。予測期間における主な動向としては、長時間作用型ビタミンB12製剤の開発、在宅診断キットの利用拡大、貧血検出における人工知能（AI）の統合、デジタル健康モニタリングツールの台頭、診断技術の進歩などが挙げられます。

ビタミンB12欠乏症の有病率の増加は、今後数年間の悪性貧血診断および治療市場の成長を促進すると予想されます。ビタミンB12欠乏症は、体内で赤血球を十分に産生するのに十分な量のビタミンが不足することで発生し、疲労、脱力感、神経学的問題などの症状を引き起こします。ビタミンB12欠乏症の有病率は、植物性食生活の普及により上昇しているが、植物性食生活ではB12の十分な天然供給源がないことが多く、適切なサプリメントを摂取しないと摂取量が不足する可能性があります。この欠乏症は悪性貧血診断および治療の必要性を裏付けています。B12レベルの低下は赤血球産生を直接阻害するため、医師は主要かつ効果的な治療法としてB12サプリメントの投与を促しています。例えば、2023年2月、国民保健サービス（NHS）の報告によると、ビタミンB12と葉酸の欠乏は高齢者に多く、75歳以上では約10人に1人、65歳から74歳では20人に1人が罹患しています。したがって、ビタミンB12欠乏症の有病率の上昇が悪性貧血診断および治療市場の成長に寄与しています。

悪性貧血診断および治療市場の主要企業は、患者のアドヒアランスと長期的な疾患管理を改善するために、ビタミンB12維持療法などの革新的なソリューションの開発に注力しています。ビタミンB12維持療法は、適切なB12レベルを維持し、欠乏症に関連する症状の再発を予防するために、経口錠剤、注射、点鼻薬による定期的かつ継続的な補給を行うものです。例えば、2024年2月、インドの製薬会社Lupin Pharmaceuticals Inc.は、非侵襲的なビタミンB12補給の代替品としてシアノコバラミン点鼻スプレー（500mcg/スプレー）を発売しました。この点鼻スプレーは、経口ビタミンB12製剤で課題に直面している悪性貧血患者に便利で効果的な選択肢を提供します。ビタミンB12の吸収を高め、ビタミンB12欠乏症の管理をサポートし、最終的には患者のコンプライアンスと治療成績を改善します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の悪性貧血診断および治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の悪性貧血診断および治療市場：成長率分析
• 世界の悪性貧血診断および治療市場の実績：規模と成長, 2019-2024
• 世界の悪性貧血診断および治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界の悪性貧血診断および治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の悪性貧血診断および治療市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 完全血球数検査
• ビタミンB12欠乏症検査
• 内因子欠乏検査
• 世界の悪性貧血診断および治療市場：治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ビタミンB12注射
• ビタミンB12錠剤
• スプレー
• 世界の悪性貧血診断および治療市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注射
• 経口
• 鼻腔内
• 世界の悪性貧血診断および治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• 診断センター
• その他のエンドユーザー
• 世界の悪性貧血診断および治療市場、全血球算定（CBC）検査、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 赤血球数
• ヘモグロビン濃度
• ヘマトクリット値
• 平均赤血球容積（MCV）
• 白血球数
• 血小板数
• 世界の悪性貧血診断および治療市場、ビタミンB12欠乏症検査、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 血清ビタミンB12検査
• メチルマロン酸（MMA）検査
• ホモシステイン検査
• ホロトランスコバラミン（活性ビタミンB12）検査
• 世界の悪性貧血診断および治療市場、内因子欠乏検査、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 内因子抗体検査
• 壁細胞抗体検査
• シリングテスト
• ガストリンレベル検査

第7章 地域別・国別分析

• 世界の悪性貧血診断および治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の悪性貧血診断および治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 悪性貧血診断および治療市場：競合情勢
• 悪性貧血診断および治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F.Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sanofi S.A.
• Bristol Myers Squibb Company
• Thermo Fisher Scientific Inc.
• GSK plc
• Takeda Pharmaceutical Company Limited
• Lupin Limited
• Eli Lilly and Company
• Amgen Inc.
• DSM Nutritional Products AG
• Bio-Rad Laboratories Inc.
• CSL Vifor Pharma
• Daiichi Sankyo Co. Ltd.
• Par Pharmaceutical Companies Inc.
• AdvaCare Pharma
• Monobind Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 悪性貧血診断および治療市場2029：新たな機会を提供する国
• 悪性貧血診断および治療市場2029：新たな機会を提供するセグメント
• 悪性貧血診断および治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Pernicious anemia diagnosis and treatment refers to the process of identifying and managing a condition where the body is unable to produce sufficient healthy red blood cells due to impaired absorption of vitamin B12, often due to a lack of intrinsic factor. The diagnosis involves evaluating clinical symptoms such as fatigue, weakness, and neurological issues. Treatment aims to restore vitamin B12 levels, promote normal red blood cell production, alleviate symptoms, and prevent long-term health complications.

The primary types of pernicious anemia diagnosis and treatment include complete blood count (CBC) tests, vitamin B12 deficiency tests, and intrinsic factor deficiency tests. A CBC test is a common blood test that measures various blood components, helping to identify abnormal levels of red blood cells and hemoglobin, which can indicate anemia and assist in diagnosing the condition. Treatments vary and include vitamin B12 injections, oral vitamin B12 pills, and intranasal sprays, all of which are administered via different routes such as injection, oral, and intranasal. These treatments are utilized by end users, including hospitals, clinics, diagnostic centers, and other healthcare settings.

The pernicious anemia diagnosis and treatment market research report is one of a series of new reports from The Business Research Company that provides pernicious anemia diagnosis and treatment market statistics, including the pernicious anemia diagnosis and treatment industry's global market size, regional shares, competitors with an pernicious anemia diagnosis and treatment market share, detailed pernicious anemia diagnosis and treatment market segments, market trends and opportunities, and any further data you may need to thrive in the pernicious anemia diagnosis and treatment industry. This pernicious anemia diagnosis and treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pernicious anemia diagnosis and treatment market size has grown strongly in recent years. It will grow from $1.42 billion in 2024 to $1.52 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth during the historic period can be attributed to rising awareness of vitamin B12 deficiency, the increasing prevalence of autoimmune disorders, the growing geriatric population, enhanced physician education on anemia, and the availability of both oral and injectable vitamin B12 treatments.

The pernicious anemia diagnosis and treatment market size is expected to see strong growth in the next few years. It will grow to $1.97 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth during the forecast period can be attributed to the expansion of telemedicine services, increasing demand for early diagnosis, a growing focus on personalized medicine, government screening initiatives, and a rising patient preference for non-invasive treatments. Key trends in the forecast period include the development of long-acting vitamin B12 formulations, a growing use of home-based diagnostic kits, the integration of artificial intelligence (AI) in anemia detection, the rise of digital health monitoring tools, and advancements in diagnostic technologies.

The increasing prevalence of vitamin B12 deficiency is expected to fuel growth in the pernicious anemia diagnosis and treatment market in the coming years. Vitamin B12 deficiency occurs when the body lacks sufficient amounts of the vitamin to produce enough red blood cells, leading to symptoms such as fatigue, weakness, and neurological issues. The prevalence of vitamin B12 deficiency is rising due to the growing adoption of plant-based diets, which often lack adequate natural sources of B12 and may result in insufficient intake without proper supplementation. This deficiency supports the need for pernicious anemia diagnosis and treatment, as low B12 levels directly hinder red blood cell production, prompting doctors to administer B12 supplementation as a primary and effective treatment approach. For example, in February 2023, a report by the National Health Service (NHS) indicated that both vitamin B12 and folate deficiencies are more common among older adults, affecting approximately 1 in 10 individuals aged 75 or older and 1 in 20 of those aged 65 to 74. Therefore, the rising prevalence of vitamin B12 deficiency is contributing to the growth of the pernicious anemia diagnosis and treatment market.

Leading companies in the pernicious anemia diagnosis and treatment market are focusing on developing innovative solutions, such as vitamin B12 maintenance therapy, to improve patient adherence and long-term disease management. Vitamin B12 maintenance therapy involves regular, ongoing supplementation through oral tablets, injections, or nasal sprays to maintain adequate B12 levels and prevent the recurrence of deficiency-related symptoms. For example, in February 2024, Lupin Pharmaceuticals Inc., a pharmaceutical company based in India, launched a cyanocobalamin nasal spray (500 mcg/spray) as a non-invasive alternative for vitamin B12 supplementation. This nasal spray offers a convenient and effective option for patients with pernicious anemia who face challenges with oral vitamin B12 forms. It enhances B12 absorption and supports the management of vitamin B12 deficiency, ultimately improving patient compliance and treatment outcomes.

In February 2025, Lightstone Group, a U.S.-based investment firm, acquired Pfizer's Durham facility for $41.1 million. This acquisition enabled the firm to add a move-in-ready, state-of-the-art clinical supply cGMP facility, built to meet the highest quality standards, to its growing portfolio. Pfizer Inc., a U.S.-based manufacturer, produces vitamin B12 capsules for pernicious anemia treatment.

Major players in the pernicious anemia diagnosis and treatment market are Pfizer Inc., F.Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., GSK plc, Takeda Pharmaceutical Company Limited, Lupin Limited, Eli Lilly and Company, Amgen Inc., DSM Nutritional Products AG, Bio-Rad Laboratories Inc., CSL Vifor Pharma, Daiichi Sankyo Co. Ltd., Par Pharmaceutical Companies Inc., AdvaCare Pharma, and Monobind Inc.

North America was the largest region in the pernicious anemia diagnosis and treatment market in 2024. The regions covered in pernicious anemia diagnosis and treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pernicious anemia diagnosis and treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pernicious anemia diagnosis and treatment market consists of revenues earned by entities by providing services such as antibody testing, neurological evaluation services, nutritional counseling, and telemedicine consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. The pernicious anemia diagnosis and treatment market also includes sales of methylcobalamin supplements, combination supplements, and anemia management trackers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pernicious Anemia Diagnosis And Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pernicious anemia diagnosis and treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pernicious anemia diagnosis and treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pernicious anemia diagnosis and treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Complete Blood Count Test; Vitamin B12 Deficiency test; Intrinsic Factor Deficiency Test
• 2) By Treatment: Vitamin B12 Injections; Vitamin B12 Pills; Spray
• 3) By Route Of Administration: Injection; Oral; Intranasal
• 4) By End-User: Hospitals; Clinics; Diagnostic Centres; Other End-users
• Subsegments:
• 1) By Complete Blood Count (CBC) Test: Red Blood Cell Count; Hemoglobin Concentration; Hematocrit Levels; Mean Corpuscular Volume (MCV); White Blood Cell Count; Platelet Count
• 2) By Vitamin B12 Deficiency Test: Serum Vitamin B12 Test; Methylmalonic Acid (MMA) Test; Homocysteine Test; Holotranscobalamin (Active B12) Test
• 3) By Intrinsic Factor Deficiency Test: Intrinsic Factor Antibody Test; Parietal Cell Antibody Test; Schilling Test; Gastrin Level Test
• Companies Mentioned: Pfizer Inc.; F.Hoffmann-La Roche Ltd.; AbbVie Inc.; Bayer AG; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pernicious Anemia Diagnosis And Treatment Market Characteristics

3. Pernicious Anemia Diagnosis And Treatment Market Trends And Strategies

4. Pernicious Anemia Diagnosis And Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Pernicious Anemia Diagnosis And Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pernicious Anemia Diagnosis And Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pernicious Anemia Diagnosis And Treatment Market Growth Rate Analysis
• 5.4. Global Pernicious Anemia Diagnosis And Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pernicious Anemia Diagnosis And Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pernicious Anemia Diagnosis And Treatment Total Addressable Market (TAM)

6. Pernicious Anemia Diagnosis And Treatment Market Segmentation

• 6.1. Global Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Complete Blood Count Test
• Vitamin B12 Deficiency test
• Intrinsic Factor Deficiency Test
• 6.2. Global Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vitamin B12 Injections
• Vitamin B12 Pills
• Spray
• 6.3. Global Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injection
• Oral
• Intranasal
• 6.4. Global Pernicious Anemia Diagnosis And Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Diagnostic Centres
• Other End-Users
• 6.5. Global Pernicious Anemia Diagnosis And Treatment Market, Sub-Segmentation Of Complete Blood Count (CBC) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Red Blood Cell Count
• Hemoglobin Concentration
• Hematocrit Levels
• Mean Corpuscular Volume (MCV)
• White Blood Cell Count
• Platelet Count
• 6.6. Global Pernicious Anemia Diagnosis And Treatment Market, Sub-Segmentation Of Vitamin B12 Deficiency Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Serum Vitamin B12 Test
• Methylmalonic Acid (MMA) Test
• Homocysteine Test
• Holotranscobalamin (Active B12) Test
• 6.7. Global Pernicious Anemia Diagnosis And Treatment Market, Sub-Segmentation Of Intrinsic Factor Deficiency Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intrinsic Factor Antibody Test
• Parietal Cell Antibody Test
• Schilling Test
• Gastrin Level Test

7. Pernicious Anemia Diagnosis And Treatment Market Regional And Country Analysis

• 7.1. Global Pernicious Anemia Diagnosis And Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pernicious Anemia Diagnosis And Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pernicious Anemia Diagnosis And Treatment Market

• 8.1. Asia-Pacific Pernicious Anemia Diagnosis And Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pernicious Anemia Diagnosis And Treatment Market

• 9.1. China Pernicious Anemia Diagnosis And Treatment Market Overview
• 9.2. China Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pernicious Anemia Diagnosis And Treatment Market

• 10.1. India Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pernicious Anemia Diagnosis And Treatment Market

• 11.1. Japan Pernicious Anemia Diagnosis And Treatment Market Overview
• 11.2. Japan Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pernicious Anemia Diagnosis And Treatment Market

• 12.1. Australia Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pernicious Anemia Diagnosis And Treatment Market

• 13.1. Indonesia Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pernicious Anemia Diagnosis And Treatment Market

• 14.1. South Korea Pernicious Anemia Diagnosis And Treatment Market Overview
• 14.2. South Korea Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pernicious Anemia Diagnosis And Treatment Market

• 15.1. Western Europe Pernicious Anemia Diagnosis And Treatment Market Overview
• 15.2. Western Europe Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pernicious Anemia Diagnosis And Treatment Market

• 16.1. UK Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pernicious Anemia Diagnosis And Treatment Market

• 17.1. Germany Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pernicious Anemia Diagnosis And Treatment Market

• 18.1. France Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pernicious Anemia Diagnosis And Treatment Market

• 19.1. Italy Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pernicious Anemia Diagnosis And Treatment Market

• 20.1. Spain Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pernicious Anemia Diagnosis And Treatment Market

• 21.1. Eastern Europe Pernicious Anemia Diagnosis And Treatment Market Overview
• 21.2. Eastern Europe Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pernicious Anemia Diagnosis And Treatment Market

• 22.1. Russia Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pernicious Anemia Diagnosis And Treatment Market

• 23.1. North America Pernicious Anemia Diagnosis And Treatment Market Overview
• 23.2. North America Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pernicious Anemia Diagnosis And Treatment Market

• 24.1. USA Pernicious Anemia Diagnosis And Treatment Market Overview
• 24.2. USA Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pernicious Anemia Diagnosis And Treatment Market

• 25.1. Canada Pernicious Anemia Diagnosis And Treatment Market Overview
• 25.2. Canada Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pernicious Anemia Diagnosis And Treatment Market

• 26.1. South America Pernicious Anemia Diagnosis And Treatment Market Overview
• 26.2. South America Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pernicious Anemia Diagnosis And Treatment Market

• 27.1. Brazil Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pernicious Anemia Diagnosis And Treatment Market

• 28.1. Middle East Pernicious Anemia Diagnosis And Treatment Market Overview
• 28.2. Middle East Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pernicious Anemia Diagnosis And Treatment Market

• 29.1. Africa Pernicious Anemia Diagnosis And Treatment Market Overview
• 29.2. Africa Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pernicious Anemia Diagnosis And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pernicious Anemia Diagnosis And Treatment Market Competitive Landscape And Company Profiles

• 30.1. Pernicious Anemia Diagnosis And Treatment Market Competitive Landscape
• 30.2. Pernicious Anemia Diagnosis And Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F.Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Pernicious Anemia Diagnosis And Treatment Market Other Major And Innovative Companies

• 31.1. Sanofi S.A.
• 31.2. Bristol Myers Squibb Company
• 31.3. Thermo Fisher Scientific Inc.
• 31.4. GSK plc
• 31.5. Takeda Pharmaceutical Company Limited
• 31.6. Lupin Limited
• 31.7. Eli Lilly and Company
• 31.8. Amgen Inc.
• 31.9. DSM Nutritional Products AG
• 31.10. Bio-Rad Laboratories Inc.
• 31.11. CSL Vifor Pharma
• 31.12. Daiichi Sankyo Co. Ltd.
• 31.13. Par Pharmaceutical Companies Inc.
• 31.14. AdvaCare Pharma
• 31.15. Monobind Inc.

32. Global Pernicious Anemia Diagnosis And Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pernicious Anemia Diagnosis And Treatment Market

34. Recent Developments In The Pernicious Anemia Diagnosis And Treatment Market

35. Pernicious Anemia Diagnosis And Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Pernicious Anemia Diagnosis And Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pernicious Anemia Diagnosis And Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pernicious Anemia Diagnosis And Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer